Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Vericel is a US-based biopharmaceutical company specializing in the development and commercialization of advanced cell-based therapies and regenerative medicine products. It offers innovative solutions for cartilage repair and the treatment of severe burns, aiming to provide lasting patient benefit.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Vericel is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Vericel last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.04 USD.
Across its last 3 earnings reports, Vericel stock moved by ±2.9% on average the following day. The largest reaction was -4.5% on 05/07/2026; 2 of 3 reactions were positive.
Vericel has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.